TELA Bio (TELA) Competitors $1.78 -0.02 (-1.33%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. BWAY, OM, STIM, SGHT, SI, NYXH, INGN, INFU, KRMD, and MGRMShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Brainsway (BWAY), Outset Medical (OM), Neuronetics (STIM), Sight Sciences (SGHT), Shoulder Innovations (SI), Nyxoah (NYXH), Inogen (INGN), InfuSystem (INFU), KORU Medical Systems (KRMD), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors Brainsway Outset Medical Neuronetics Sight Sciences Shoulder Innovations Nyxoah Inogen InfuSystem KORU Medical Systems Monogram Orthopaedics TELA Bio (NASDAQ:TELA) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Do institutionals and insiders believe in TELA or BWAY? 94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by company insiders. Comparatively, 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger earnings and valuation, TELA or BWAY? Brainsway has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M1.01-$37.84M-$1.12-1.57Brainsway$41.02M7.03$2.92M$0.2658.69 Does the media favor TELA or BWAY? In the previous week, Brainsway had 5 more articles in the media than TELA Bio. MarketBeat recorded 8 mentions for Brainsway and 3 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Brainsway's score of 0.30 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Brainsway 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is TELA or BWAY more profitable? Brainsway has a net margin of 11.60% compared to TELA Bio's net margin of -54.12%. Brainsway's return on equity of 8.97% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-54.12% -329.48% -57.34% Brainsway 11.60%8.97%5.65% Do analysts recommend TELA or BWAY? TELA Bio currently has a consensus target price of $4.50, indicating a potential upside of 155.68%. Brainsway has a consensus target price of $18.00, indicating a potential upside of 17.96%. Given TELA Bio's higher possible upside, analysts plainly believe TELA Bio is more favorable than Brainsway.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Brainsway 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, TELA or BWAY? TELA Bio has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. SummaryBrainsway beats TELA Bio on 12 of the 16 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.31M$3.10B$5.77B$9.78BDividend YieldN/A2.26%3.95%4.03%P/E Ratio-1.577.4422.3224.91Price / Sales1.01396.73467.21121.85Price / CashN/A44.4437.7659.36Price / Book7.658.0610.106.62Net Income-$37.84M-$54.08M$3.26B$265.42M7 Day Performance4.14%3.95%3.91%3.58%1 Month Performance-8.33%3.02%3.74%0.46%1 Year Performance-40.14%6.84%37.68%19.41% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio3.102 of 5 stars$1.76-2.2%$4.50+155.7%-40.0%$71.31M$69.30M-1.57120Positive NewsBWAYBrainsway3.0568 of 5 stars$14.85+14.4%$18.00+21.2%+97.5%$245.33M$41.02M57.12120Analyst ForecastHigh Trading VolumeOMOutset Medical1.3446 of 5 stars$13.67+2.9%$24.67+80.4%+40.1%$236.11M$113.69M-0.67520STIMNeuronetics2.0975 of 5 stars$3.54+6.0%$7.00+97.7%+256.9%$220.86M$74.89M-3.13180Positive NewsSGHTSight Sciences1.4111 of 5 stars$4.19-0.2%$4.27+1.8%-40.0%$219.94M$79.87M-4.36210SIShoulder Innovations2.533 of 5 stars$14.34+1.8%N/AN/A$214.57MN/A-0.4861News CoverageAnalyst ForecastGap UpNYXHNyxoah2.4847 of 5 stars$6.57+5.6%$15.00+128.3%-26.3%$211.86M$4.89M-3.08110Gap UpINGNInogen4.3426 of 5 stars$7.55+1.2%$11.00+45.7%-37.2%$201.72M$335.70M-7.121,030Positive NewsINFUInfuSystem2.5762 of 5 stars$9.53-1.0%$12.50+31.2%+54.8%$194.66M$139.89M158.86410KRMDKORU Medical Systems1.2782 of 5 stars$4.21+1.0%$4.63+9.9%+82.1%$192.80M$33.65M-46.7880Positive NewsMGRMMonogram Orthopaedics1.9232 of 5 stars$5.32-0.2%$5.40+1.5%+73.0%$190.22M$370K-10.6428 Related Companies and Tools Related Companies Brainsway Competitors Outset Medical Competitors Neuronetics Competitors Sight Sciences Competitors Shoulder Innovations Competitors Nyxoah Competitors Inogen Competitors InfuSystem Competitors KORU Medical Systems Competitors Monogram Orthopaedics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access